Genomic Health (GHDX) Misses Q1 EPS by 4c
Tweet
Share
E-mailGet Alerts GHDX Hot Sheet
Price: $63.44 --0%
Financial Fact:
Income (loss) before income taxes: -14.81M
Today's EPS Names:
LUNA, BTTX, VAXX, More
Financial Fact:
Income (loss) before income taxes: -14.81M
Today's EPS Names:
LUNA, BTTX, VAXX, More
Join SI Premium – FREE
Genomic Health (NASDAQ: GHDX) reported Q1 EPS of ($0.30), $0.04 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $68.2 million versus the consensus estimate of $69.9 million.
For earnings history and earnings-related data on Genomic Health (GHDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Allogene (ALLO) Reiterated at Market Outperform by Citizens: 'ALPHA3 Trial is On-Track'
- Reading (RDI) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
